Zenozyme Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 574.24%
(FY 2023)
- Profit 262.31%
(FY 2023)
- Ebitda 166.74%
(FY 2023)
- Net Worth 108.61%
(FY 2023)
- Total Assets 38.85%
(FY 2023)
About Zenozyme Biotech
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chakrapani Ruddraramker, Ragunandan Rudraramker, and Ruddararamker Dhananjaya serve as directors at the Company.
- CIN/LLPIN
U74900TG2015PTC097109
- Company No.
097109
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Tandur, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Zenozyme Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chakrapani Ruddraramker  | Director | 05-Jan-2015 | Current |
| Ragunandan Rudraramker | Director | 14-Jun-2022 | Current |
| Ruddararamker Dhananjaya | Director | 05-Jan-2015 | Current |
Financial Performance of Zenozyme Biotech.
Zenozyme Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 574.24% increase. The company also saw a substantial improvement in profitability, with a 262.31% increase in profit. The company's net worth Soared by an impressive increase of 108.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenozyme Biotech?
In 2023, Zenozyme Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
United Alacrity (India) Private LimitedActive 20 years 1 monthChakrapani Ruddraramker is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zenozyme Biotech?
Unlock and access historical data on people associated with Zenozyme Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenozyme Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenozyme Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
